Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Work In Process (2022 - 2026)

HeartSciences filings provide 5 years of Work In Process readings, the most recent being $21741.0 for Q1 2026.

  • On a quarterly basis, Work In Process changed 0.0% to $21741.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $21741.0, a 0.0% change, with the full-year FY2025 number at $21741.0, changed 0.0% from a year prior.
  • Work In Process hit $21741.0 in Q1 2026 for HeartSciences, roughly flat from $21741.0 in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $21741.0 in Q2 2022 to a low of $21741.0 in Q2 2022.
  • Median Work In Process over the past 5 years was $21741.0 (2022), compared with a mean of $21741.0.
  • The widest YoY moves for Work In Process: up 0.0% in 2023, down 0.0% in 2023.
  • HeartSciences' Work In Process stood at $21741.0 in 2022, then changed by 0.0% to $21741.0 in 2023, then changed by 0.0% to $21741.0 in 2024, then changed by 0.0% to $21741.0 in 2025, then changed by 0.0% to $21741.0 in 2026.
  • The last three reported values for Work In Process were $21741.0 (Q1 2026), $21741.0 (Q4 2025), and $21741.0 (Q3 2025) per Business Quant data.